Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;89(8):2396-2406.
doi: 10.1111/bcp.15703. Epub 2023 Mar 20.

Evaluation of acquired antithrombin deficiency in paediatric patients supported on extracorporeal membrane oxygenation

David E Procaccini  1 , Jennifer Roem  2 , Derek K Ng  2 , Thomas E Rappold  3 , Dawoon Jung  4 , Jogarao V S Gobburu  4 , Melania M Bembea  3
Affiliations
Free article

Evaluation of acquired antithrombin deficiency in paediatric patients supported on extracorporeal membrane oxygenation

David E Procaccini et al. Br J Clin Pharmacol. 2023 Aug.
Free article

Abstract

Aims: There remains a paucity of literature regarding best practice for antithrombin (AT) monitoring, dosing and dose-response in paediatric extracorporeal membrane oxygenation (ECMO) patients.

Methods: We conducted a retrospective cohort study at a quaternary care paediatric intensive care unit in all patients <18 years of age supported on ECMO from 1 June 2011 to 30 April 2020. Adverse events and outcomes were characterized for all ECMO runs. AT activity and replacement were characterized and compared between two clinical protocols. AT activities measured post- vs. pre-AT replacement were compared in order to characterize a dose-response relationship.

Results: The final cohort included 191 patients with 201 ECMO runs and 2028 AT activity measurements. The median AT activity was 65% (interquartile range [IQR], 51-82) and 879 (43.3%) measurements met the criteria of deficient. The overall median AT dose and increase in AT activity were 50.6 units/kg/dose (IQR, 39.5-67.2) and 23.5% (IQR, 9.8-36.0), respectively. In the protocol that restricted AT activity measurements to clinical scenarios concerning for heparin resistance, there was significantly higher dosing in conjunction with significantly fewer overall administrations. Approximately one third of AT activity remained deficient after repletion. There was no difference in mechanical complications, reasons for discontinuation of ECMO support, time on ECMO or survival between protocols.

Conclusions: There was a high prevalence of AT deficiency in paediatric ECMO patients. An AT replacement protocol based on evaluating heparin resistance is associated with fewer AT administrations, with similar circuit and patient outcomes. Further data are needed to identify optimal dosing strategies.

Keywords: antithrombin; extracorporeal membrane oxygenation; heparin; paediatric.

PubMed Disclaimer

References

REFERENCES

    1. Thrombate [package insert]. Research Triangle Park, NC: Grifols Therapeutics, Inc.; 2013.
    1. Badrin O, Kushairi S, Zakaria Z, Sachithanandan A. Successful anticoagulation with fresh frozen plasma for cardiopulmonary bypass in a patient with heparin resistance: a cautionary tale. BMJ Case Rep. 2013;2013:bcr2013009112.
    1. Nishimuru T, Takagi Y. Strategy for cardiovascular surgery in patients with antithrombin deficiency. Ann Thorac Cardiovasc Surg. 2018;24(4):187-192. doi:10.5761/atcs.oa.18-00030
    1. Bembea MM, Annich G, Rycus P, Oldenburg G, Berkowitz I, Pronovost P. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey. Pediatr Crit Care Med. 2013;14(2):e77-e84. doi:10.1097/PCC.0b013e31827127e4
    1. Wong TE, Huang YS, Weiser J, et al. Antithrombin concentrate use in children: a multicenter cohort study. J Pediatr. 2013;163(5):1329-1334.e1.

Publication types

MeSH terms

LinkOut - more resources